Cargando…

Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins

Supramolecular chemistry holds great potential for the design of versatile and safe carriers for therapeutic proteins and peptides. Nanocarriers can be designed to meet specific criteria for given application (exact drug, administration route, target tissue, etc.). However, alterations in the topolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Knauer, Nadezhda, Pashkina, Ekaterina, Apartsin, Evgeny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410174/
https://www.ncbi.nlm.nih.gov/pubmed/30795556
http://dx.doi.org/10.3390/pharmaceutics11020091
_version_ 1783402179616309248
author Knauer, Nadezhda
Pashkina, Ekaterina
Apartsin, Evgeny
author_facet Knauer, Nadezhda
Pashkina, Ekaterina
Apartsin, Evgeny
author_sort Knauer, Nadezhda
collection PubMed
description Supramolecular chemistry holds great potential for the design of versatile and safe carriers for therapeutic proteins and peptides. Nanocarriers can be designed to meet specific criteria for given application (exact drug, administration route, target tissue, etc.). However, alterations in the topology of formulation components can drastically change their activity. This is why the supramolecular topology of therapeutic nanoconstructions has to be considered. Herein, we discuss several topological groups used for the design of nanoformulations for peptide and protein delivery: modification of polypeptide chains by host-guest interactions; packaging of proteins and peptides into liposomes; complexation and conjugation with dendrimers. Each topological type has its own advantages and disadvantages, so careful design of nanoformulations is needed. Ideally, each case where nanomedicine is needed requires a therapeutic construction specially created for that taking into account features of the administration route, target tissue, or organ, properties of a drug, its bioavailability, etc. The wide number of studies in the field of protein delivery by supramolecular and nanocarriers for proteins and peptides evidence their increasing potential for different aspects of the innovative medicine. Although significant progress has been achieved in the field, there are several remaining challenges to be overcome in future.
format Online
Article
Text
id pubmed-6410174
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64101742019-03-29 Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins Knauer, Nadezhda Pashkina, Ekaterina Apartsin, Evgeny Pharmaceutics Review Supramolecular chemistry holds great potential for the design of versatile and safe carriers for therapeutic proteins and peptides. Nanocarriers can be designed to meet specific criteria for given application (exact drug, administration route, target tissue, etc.). However, alterations in the topology of formulation components can drastically change their activity. This is why the supramolecular topology of therapeutic nanoconstructions has to be considered. Herein, we discuss several topological groups used for the design of nanoformulations for peptide and protein delivery: modification of polypeptide chains by host-guest interactions; packaging of proteins and peptides into liposomes; complexation and conjugation with dendrimers. Each topological type has its own advantages and disadvantages, so careful design of nanoformulations is needed. Ideally, each case where nanomedicine is needed requires a therapeutic construction specially created for that taking into account features of the administration route, target tissue, or organ, properties of a drug, its bioavailability, etc. The wide number of studies in the field of protein delivery by supramolecular and nanocarriers for proteins and peptides evidence their increasing potential for different aspects of the innovative medicine. Although significant progress has been achieved in the field, there are several remaining challenges to be overcome in future. MDPI 2019-02-21 /pmc/articles/PMC6410174/ /pubmed/30795556 http://dx.doi.org/10.3390/pharmaceutics11020091 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Knauer, Nadezhda
Pashkina, Ekaterina
Apartsin, Evgeny
Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins
title Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins
title_full Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins
title_fullStr Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins
title_full_unstemmed Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins
title_short Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins
title_sort topological aspects of the design of nanocarriers for therapeutic peptides and proteins
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410174/
https://www.ncbi.nlm.nih.gov/pubmed/30795556
http://dx.doi.org/10.3390/pharmaceutics11020091
work_keys_str_mv AT knauernadezhda topologicalaspectsofthedesignofnanocarriersfortherapeuticpeptidesandproteins
AT pashkinaekaterina topologicalaspectsofthedesignofnanocarriersfortherapeuticpeptidesandproteins
AT apartsinevgeny topologicalaspectsofthedesignofnanocarriersfortherapeuticpeptidesandproteins